findmyKOL

William Kreisle, MD

Basic profile

St. Luke's Mountain States Tumor Institute

ORCIDNone on fileNPI
RegionBoise, ID · WestSpecialtyHematology / OncologyFocusOncology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

William Kreisle is an Oncology physician affiliated with St. Luke's Mountain States Tumor Institute. OpenAlex indexes 5 publications with 550 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
5publications

Distinct works indexed by OpenAlex.

550citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    62.2%
    Kinase inhibitor24.3%
    Jakafi44%Calquence24%Imbruvica16%Imatinib Mesylate15%
    Part D<11 patients
    Thalidomide Analog23.8%
    Revlimid100%
    Part D13 patients

    + 2 more classes in this area

  • Dermatology

    16.7%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor16.7%
    Acyclovir100%
    Part D27 patients
  • Anti-infectives

    7.9%
    Short-acting sulfonamides4.7%
    Sulfamethoxazole-Trimethoprim100%
    Part D<11 patients
    Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor3.2%
    Entecavir100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”